Technical Analysis for MYOK - MyoKardia, Inc.

Grade Last Price % Change Price Change
grade F 45.52 1.88% 0.84
MYOK closed up 1.88 percent on Friday, January 18, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical MYOK trend table...

Date Alert Name Type % Chg
Jan 17 Narrow Range Bar Range Contraction 1.88%
Jan 17 Down 3 Days in a Row Weakness 1.88%
Jan 17 Down 4 Days in a Row Weakness 1.88%
Jan 16 Narrow Range Bar Range Contraction 0.98%
Jan 16 NR7 Range Contraction 0.98%
Jan 16 Inside Day Range Contraction 0.98%
Jan 16 Down 3 Days in a Row Weakness 0.98%
Jan 14 Narrow Range Bar Range Contraction -1.54%
Jan 14 NR7 Range Contraction -1.54%
Jan 14 NR7-2 Range Contraction -1.54%

Older signals for MYOK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
MyoKardia, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). The company also develops DCM-1, a product candidate that treats heritable dilated cardiomyopathy (DCM) by restoring normal contractility in the diseased DCM heart. In addition, it develops HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients; and LUS-1, a product candidate, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart. MyoKardia, Inc. has a strategic collaboration with Sanofi S.A. The company was founded in 2012 and is headquartered in South San Francisco, California.
Is MYOK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 67.78
52 Week Low 39.16
Average Volume 298,278
200-Day Moving Average 53.5242
50-Day Moving Average 52.4866
20-Day Moving Average 46.095
10-Day Moving Average 45.33
Average True Range 2.8349
ADX 21.37
+DI 17.3679
-DI 25.0762
Chandelier Exit (Long, 3 ATRs ) 45.3553
Chandelier Exit (Short, 3 ATRs ) 47.6647
Upper Bollinger Band 51.8781
Lower Bollinger Band 40.3119
Percent B (%b) 0.45
BandWidth 25.092092
MACD Line -2.0527
MACD Signal Line -2.4301
MACD Histogram 0.3775
Fundamentals Value
Market Cap 1.43 Billion
Num Shares 31.5 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -70.03
Price-to-Sales 26.88
Price-to-Book 9.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 47.72
Resistance 3 (R3) 47.62 46.79 47.35
Resistance 2 (R2) 46.79 46.23 46.84 47.23
Resistance 1 (R1) 46.16 45.89 46.48 46.25 47.11
Pivot Point 45.33 45.33 45.49 45.38 45.33
Support 1 (S1) 44.69 44.77 45.01 44.79 43.93
Support 2 (S2) 43.86 44.42 43.91 43.81
Support 3 (S3) 43.23 43.86 43.69
Support 4 (S4) 43.32